The PFA-100™ system for the assessment of platelet function in normotensive and hypertensive pregnancies

Clinical and Laboratory Haematology

Volumn 23, Issue 2, 2001, Pages 131-134

  Marietta, Marco ^a,b   Castelli, Ilaria ^a   Piccinini, Federica ^a   Neri, Isabella ^a   Bertesi, Marcello ^a   Facchinetti, Fabio ^a   Torelli, Giuseppe ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Gestational hypertension; L Arginine; L Arginine: Nitric Oxide pathway; PFA 100 ; Platelet aggregation; Pregnancy

Indexed keywords

ARGININE; NITRIC OXIDE;

ADULT; ANTICOAGULATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; INCUBATION TIME; INTERMETHOD COMPARISON; LIGHT; MATERNAL HYPERTENSION; PREGNANCY; PRIORITY JOURNAL; REGULATORY MECHANISM; SHEAR RATE; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; BLOOD; BLOOD PRESSURE; FLOW KINETICS; HYPERTENSION; INSTRUMENTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY COMPLICATION;

BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; PLATELET AGGREGATION; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RHEOLOGY;

EID: 0034742126     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.2001.00382.x     Document Type: Article

References (19)

1. Changes in platelet function in pregnancies complicated by fetal growth retardation
2. Report of the national high blood pressure education program
3. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy induced hypertension
4. Systemic and fetal-maternal nitric oxide synthesis in normal pregnancy and pre-eclampsia
5. Aggregation of blood platelets by adenosine diphosphate and its reversal
6. Low-dose aspirin to prevent pre-eclamspia in women at high risk. National institute of child health and human development network of maternal-fetal medicine units
7. Evaluation of the PFA-100™ system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease
8. CLASP: A randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women
9. TM in testing abnormalities of primary haemostasis
10. Increased platelet volume and aggregation precede the onset of pre-eclampsia
11. A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease
12. Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in pre-eclampsia and pregnancy
13. Preliminary data from a field trial of the PFA-100™ System
14. L-Arginine infusion decreases platelet aggregation through an intraplatelet nitric oxide release
15. The L-Arginine: Nitric Oxide system regulates platelet aggregation in pregnancy
16. Alterations in platelet concentration and aggregation in normal pregnancy and in pre-eclampsia
17. An L-Arginine: Nitric Oxide pathway present in human platelets regulates platelet aggregation
18. Laboratory investigation of platelet function
19. Platelets and IUGR in pre-eclampsia